Today, Monday, June 8, the Sidal Group signed a cooperation agreement with the German company “Boehringer Ingelheim” to localize the manufacturing and production of an innovative treatment for pulmonary fibrosis in Algeria. According to what was reported by the complex, the signing ceremony was supervised by the Minister of Pharmaceutical Industry, Waseem Koueidari, and the Ambassador of the Federal Republic of Germany to Algeria, Georg Felsheim. The agreement was signed by the General Director of the Saidal Complex, Mourad Belkhelfa, […] The post Sidal signs an agreement with the German “Boehringer Ingelheim” to produce an innovative treatment for pulmonary fibrosis appeared first on Al-Shorouk Online.